DeMarco Allan LLP Acted for Kernaghan & Partners Ltd. as Agent in Brokered Public Offering
DeMarco Allan LLP, with a team composed of Robert Eberschlag and Jonathan McGillivray, acted as legal counsel to Kernaghan & Partners Ltd. as agent, in connection with Liberty Biopharma Inc.'s marketed public offering of units.
Under the closing of the offering completed June 27, 2017 by way of a short-form prospectus, 3,200,900 units were sold at a price of $0.20 per unit. Kernaghan & Partners Ltd. is a full service brokerage firm offering advisory services on a global range of products to both retail as well as institutional investors. Liberty Biopharma Inc. is a clinical stage biopharmaceutical company that develops and commercializes regenerative stem cell technologies and therapeutic solutions.